يعرض 1 - 2 نتائج من 2 نتيجة بحث عن '"Megan Dupuis"', وقت الاستعلام: 0.65s تنقيح النتائج
  1. 1
    دورية أكاديمية
    The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors

    المؤلفون: Barry Paul, Yue Zhao, Gavin Loitsch, Daniel Feinberg, Parker Mathews, Ian Barak, Megan Dupuis, Zhiguo Li, Lindsay Rein, Endi Wang, Yubin Kang

    المصدر: Cancer Medicine, Vol 9, Iss 16, Pp 5869-5880 (2020)

    مصطلحات موضوعية: bone marrow fibrosis, immunohistochemical staining, JAK2, multiple myeloma, overall survival, progression free survival, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

    وصف الملف: electronic resource

    العلاقة: https://doaj.org/toc/2045-7634Test

    الوصول الحر: https://doaj.org/article/61f7841b051f4ba48d649ace03521803Test

    View record in DOAJ النص الكامل

    أضف إلى المفضلة
  2. 2
    The impact of bone marrow fibrosis and JAK2 expression on clinical outcomes in patients with newly diagnosed multiple myeloma treated with immunomodulatory agents and/or proteasome inhibitors

    المؤلفون: Gavin Loitsch, Megan Dupuis, Yue Zhao, Ian Barak, Endi Wang, Daniel Feinberg, Zhiguo Li, Barry Paul, Lindsay A.M. Rein, Parker Mathews, Yubin Kang

    المصدر: Cancer Medicine, Vol 9, Iss 16, Pp 5869-5880 (2020)
    Cancer Medicine

    مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, Biopsy, Disease, Gastroenterology, 0302 clinical medicine, Bone Marrow, Stage (cooking), Multiple myeloma, Original Research, Aged, 80 and over, progression free survival, Hematopoietic stem cell, Middle Aged, Prognosis, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunohistochemistry, Progression-Free Survival, multiple myeloma, Treatment Outcome, medicine.anatomical_structure, bone marrow fibrosis, Oncology, JAK2, 030220 oncology & carcinogenesis, Female, Megakaryocytes, Proteasome Inhibitors, Adult, medicine.medical_specialty, overall survival, lcsh:RC254-282, 03 medical and health sciences, Internal medicine, Confidence Intervals, medicine, Humans, Immunologic Factors, Radiology, Nuclear Medicine and imaging, Progression-free survival, Aged, Retrospective Studies, business.industry, Clinical Cancer Research, Janus Kinase 1, Janus Kinase 2, medicine.disease, 030104 developmental biology, Proteasome, Primary Myelofibrosis, immunohistochemical staining, Syndecan-1, Bone marrow, business, Follow-Up Studies

    الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2d2fe2d0e7d442a72e1cc1a9afb2d360Test
    https://doaj.org/article/61f7841b051f4ba48d649ace03521803Test


    أضف إلى المفضلة
أدوات البحث: أحصل على تغذية RSS — أرسل هذا البحث بالبريد الإلكتروني — حفظ البحث